-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 526.55 | 531.90 | 25 |
| 100 | 526.00 | 532.00 | 100 |
| 16 | 525.75 | 539.00 | 10 |
| 110 | 524.00 | 539.40 | 250 |
| 135 | 523.00 | 539.55 | 20 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 526.55 | 531.90 | 25 |
| 100 | 526.00 | 532.00 | 100 |
| 16 | 525.75 | 539.00 | 10 |
| 110 | 524.00 | 539.40 | 250 |
| 135 | 523.00 | 539.55 | 20 |
| 0 | Total | Total | 0 |
| Open | 526.50 |
| Previous Close | 526.20 |
| Volume | 188,527.00 |
| Value (Lacs) | 993.25 |
| VWAP | 527.86 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 9,139 |
| High | 533.25 |
| Low | 521.60 |
| UC Limit | 578.80 |
| LC Limit | 473.60 |
| 52 Week High | 1,027.80 |
| 52 Week Low | 512.40 |
| Face Value | 2.00 |
| All Time High | 1,027.80 |
| All Time Low | 319.50 |
| 20D Avg Volume | 417,077 |
| 20D Avg Delivery(%) | 26.75 |
| Book Value Per Share | 21.02 |
| Dividend Yield | 0.23 |
| TTM EPS See historical trend | 0.00 (+110.05% YoY) |
| TTM PE See historical trend | -- (Low PE) |
| P/B See historical trend | 25.07 (Low P/B) |
| Sector PE | 40.49 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
1 out of 3 years Blue Jet Healthcare has given negative returns in January.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| January | 32.89% (2025) | 32.89% | -3.79% (2024) | -3.79% | 14.55% |
Buy Blue Jet Healthcare; target of Rs 750: ICICI Securities Nov 06 2025 10:35 PM
Buy Blue Jet Healthcare; target of Rs 770: Motilal Oswal Nov 06 2025 08:55 PM
Blue Jet Healthcare AGM: u20b91.20/Share Dividend Declared, Directors Re-appointed Sep 26 2025 02:44 PM
Blue Jet Healthcare Promoter Sells 6.19% Stake via OFS Sep 15 2025 04:23 PM
but the benefits to indian firm may or may not come..first the chinese firms are huge and they all have us subs so work will somehow migrate there as they are selling subs to make them china free at least overtly . bit how adani managed to park the owner ship via funds so no one can make out but there are side letters on process . second this act is likely to be implemented via a national security agency , so compliance for indian firms is not going to be easy . in addition to fda now there will be another fed agency indian firms have to worry about . point is that this is positive but will take a decade to take effect fully and what comes to india may not be apparent..so stick with the biggest players only . at least 3 to 4 k cr annual turnover if not more . small guys will have nigh mare to comply and get fully supple china certified or have us arms to execute View more
Posted by : Charlie_Brown
Repost this message
but the benefits to indian firm may or may not come..first the chinese firms are huge and they all have us subs so work will somehow migrate there as they are selling subs to make them china free at least overtly . bit how adani managed to park the owner ship via funds so no one can make out but there are side letters on process . second this act is likely to be implemented via a national security agency , so compliance for indian firms is not going to be easy . in addition to fda now there will be another fed agency indian firms have to worry about . point is that this is positive but will take a decade to take effect fully and what comes to india may not be apparent..so stick with the biggest players only . at least 3 to 4 k cr annual turnover if not more . small guys will have nigh mare to comply and get fully supple china certified or have us arms to execute
Posted by : The Fixed Income
Repost this message
strengthen your investment portfolio with 12.44% returns vedika credit capital limited 2027 ✔️ coupon: 11.00% ✔️ rating: infomerics a- stable ✔️ tenor: 1y 4m (maturity date: 27/may/2027) senior secured | high-return | nbfc bond | listed step into stable, high-yield income with this secured nbfc bond. explore on the fixed income: https://www.thefixedincome.com/product/dvjtc1prpt0=/1100-vedika-credit-capital-limited-2027?utm_source=moneycontrol&utm_medium=forum&utm_campaign=product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
